There were 996 press releases posted in the last 24 hours and 358,326 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Esperion Confirms NEXLETOL™ (bempedoic acid) Tablets to be Included in Assessment of Non-statin Medicines for Hypercholesterolemia by ICER

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image